Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03167234
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DI3 | AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO- GLYCINE-OH | H | 1LHE | 0.74 | |
CM2 | CARBOXYMYCOBACTIN T | A,B,C | 1X8U | 0.72 | |
OSC | (2R,3AS,6R,7AS)-N-(2-{1-[AMINO(IMINO)METHYL]- 2,5-DIHYDRO-1H-PYRROL-3-YL}ETHYL)- 6-HYDROXY-1-{N-[(2S)-2-HYDROXY- 3-PHENYLPROPANOYL]PHENYLALANYL}OCTAHYDRO- 1H-INDOLE-2-CARBOXAMIDE | B,C,D | 1RIW | 0.7 | |
5AM | BENZYL {(1S)-5-AMINO-1-[(S)-HYDROXY(5- {[4-(4-PHENYLBUTANOYL)PIPERAZIN- 1-YL]METHYL}-1,2,4-OXADIAZOL-3- YL)METHYL]PENTYL}CARBAMATE | A,B,C,D | 2GDD | 0.72 | |
44U | beta-phenyl-D-phenylalanyl-N-propyl- L-prolinamide | B,D | 3DA9 | 0.8 | |
IYT | N-ALPHA-ACETYL-3,5-DIIODOTYROSYL- D-THREONINE | A | 1SDW | 0.72 | |
NHN | A,C | 2GVF | 0.73 | ||
MX4 | {1-[4-(BENZYLOXY)-4-OXOBUTANOYL]HYDRAZINO}ACETIC ACID | I | 2C2M | 0.72 | |
HPI | N-(1-CARBOXY-3-PHENYLPROPYL)PHENYLALANYL- ALPHA-ASPARAGINE | A | 1U4G | 0.77 | |
843 | N-ACETYL-N-[1-(1,1'-BIPHENYL-4- YLMETHYL)-2-OXOAZEPAN-3-YL]-O-PHOSPHONOTYROSINAMIDE | A | 1O42 | 0.71 | |
IN8 | [2-(5-MERCAPTO-[1,3,4]THIADIAZOL- 2-YLCARBAMOYL)-1-PHENYL-ETHYL]- CARBAMIC ACID BENZYL ESTER | A | 2USN | 0.73 | |
T76 | (6R,21AS)-17-CHLORO-6-CYCLOHEXYL- 2,3,6,7,10,11,19,20-OCTAHYDRO-1H,5H- PYRROLO[1,2-K][1,4,8,11,14]BENZOXATETRAAZA- CYCLOHEPTADECINE-5,8,12,21(9H,13H,21AH)- TETRONE | A,H | 1NT1 | 0.72 | |
TZT | SOBLIDOTIN | A,B,C,D | 3E22 | 0.75 | |
DP7 | AC-(D)PHE-PRO-BOROARG-OH | H | 1LHC | 0.74 | |
PP5 | METHYL (2S)-[1-((N-(NAPHTHALENEACETYL))- L-VALYL)AMINOMETHYL)HYDROXYPHOSPHINYLOXY]- 3-PHENYL PROPANOATE | A | 2WEC | 0.72 | |
PP4 | METHYL (2S)-[1-((N-FORMYL)-L-VALYL)AMINO- 2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]- 3-PHENYL PROPANOATE | A | 2WEB | 0.71 | |
VS4 | 3-[[N-[4-METHYL-PIPERAZINYL]CARBONYL]- PHENYLALANINYL-AMINO]-5-PHENYL- PENTANE-1-SULFONIC ACID BENZYLOXY- AMIDE | A | 1F2C | 0.75 | |
FRF | PHE-REDUCED-PHE | A,I | 1GVX | 0.77 | |
ZAF | O-(((1R)-((N-PHENYLMETHOXYCARBONYL- L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)- L-BENZYLACETIC ACID | A | 6CPA | 0.8 | |
PLH | METHYLAMINO-PHENYLALANYL-LEUCYL- HYDROXAMIC ACID | A | 1HFC | 0.72 | |
PLH | METHYLAMINO-PHENYLALANYL-LEUCYL- HYDROXAMIC ACID | A | 1MNC | 0.72 | |
KAF | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-phenylalanine | A | 3BKK | 0.71 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.74 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1XA7 | 0.72 | |
PG1 | PENICILLIN G ACYL-SERINE | A | 2IWC | 0.72 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1MWT | 0.72 | |
IYG | N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE | A | 1OPM | 0.73 | |
ZU5 | N-[(benzyloxy)carbonyl]-O-tert- butyl-L-threonyl-N-[(1R)-4-cyclopropyl- 4-oxo-1-{[(3S)-2-oxopyrrolidin- 3-yl]methyl}butyl]-L-leucinamide | A | 2ZU5 | 0.81 | |
C20 | ACETYL-NH-VAL-CYCLOHEXYL-CH2[NCH2CHOH]CH2- BENZYL-VAL-NH-ACETYL | A,B | 1HIH | 0.71 | |
C20 | ACETYL-NH-VAL-CYCLOHEXYL-CH2[NCH2CHOH]CH2- BENZYL-VAL-NH-ACETYL | A,B | 1HII | 0.71 | |
GSO | L-GAMMA-GLUTAMYL-S-[(2S)-2-HYDROXY- 2-PHENYLETHYL]-L-CYSTEINYLGLYCINE | A,B,C,D | 2C4J | 0.73 | |
ESY | benzyl N-[(benzyloxy)carbonyl]- L-alanyl-N~6~-[(2R,3S,4S)-3-formyl- 2-hydroxy-4-methylhexanoyl]-L-lysinate | K,Y | 3E47 | 0.77 | |
GAN | 2-[3-BENZYL-5-(1-ALANYL-AMINOETHYL)- 2,3,6,7-TETRAHYDRO-1H-AZEPIN-1- YL]-1-OXOPROPYL-VALINYL-VALINE- METHYLESTER | A | 1HBV | 0.71 | |
GPR | (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 1MTC | 0.71 | |
GPR | (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 5FWG | 0.71 | |
GPR | (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 2PGT | 0.71 | |
GPR | (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 3FYG | 0.71 | |
GPR | (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 3GST | 0.71 | |
BO9 | N1-[(1R)-1-(DIHYDROXYBORYL)ETHYL]- N2-[(TERT-BUTOXYCARBONYL)-D-GAMMA- GLUTAMYL]-N6-[(BENZYLOXY)CARBONYL- L-LYSINAMIDE | A | 1Z6F | 0.8 | |
186 | [1-(1-METHYL-4,5-DIOXO-PENT-2-ENYLCARBAMOYL)- 2-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER | X | 1U9Q | 0.89 | |
C1N | N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~- [3-FLUORO-1-(4-HYDROXYBENZYL)-2- OXOPROPYL]LEUCINAMIDE | A | 1ZCM | 0.82 | |
PSI | 2-(2-{5-[2-(2-AMINO-PROPIONYLAMINO)- PROPIONYLAMINO]-4-HYDROXY-6-PHENYL- HEXANOYLAMINO}-3-METHYL-BUTYRYLAMINO)- 3-METHYL-BUTYRIC ACID METHYL ESTER | B | 1SIV | 0.75 | |
PSI | 2-(2-{5-[2-(2-AMINO-PROPIONYLAMINO)- PROPIONYLAMINO]-4-HYDROXY-6-PHENYL- HEXANOYLAMINO}-3-METHYL-BUTYRYLAMINO)- 3-METHYL-BUTYRIC ACID METHYL ESTER | B | 1AAQ | 0.75 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A,B | 2ZOF | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 2HPT | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 1TXR | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 1XRY | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 2EK9 | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 1HS6 | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 2DQM | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 3EBH | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A | 1GW6 | 0.74 | |
BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)- 4-METHYL-PENTANOIC ACID | A,B | 2ZOG | 0.74 | |
X22 | (3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- N-(diphenylmethyl)-7-(hydroxymethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D | 3CLX | 0.74 | |
X22 | (3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- N-(diphenylmethyl)-7-(hydroxymethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D | 3CM7 | 0.74 | |
ZRA | BENZOYL-ARGININE-ALANINE-METHYL KETONE | A | 2AIM | 0.85 | |
FRG | 2-[3-METHYL-4-(N-METHYL-GUANIDINO)- BUTYRYLAMINO]-3-(4-PHENYLETHYNYL- PHENYL)-PROPIONIC ACID METHYL ESTER | A,B | 1M48 | 0.71 | |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.72 | |
0E4 | N-acetyl-L-tyrosyl-L-valyl-L-alanyl- L-aspartic acid | B,D | 3GJS | 0.72 | |
ALZ | H,I | 1AFE | 0.87 | ||
FPB | N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN- 2-YL}METHYL)BENZAMIDE | A,B | 2BUB | 0.72 | |
PH0 | N-{(2S)-3-[(R)-[(1R)-1-amino-2- phenylethyl](hydroxy)phosphoryl]- 2-benzylpropanoyl}-L-phenylalanine | A | 2R59 | 0.72 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.77 | |
FNH | (2R)-({N-[(3S)-3-({[(3S,6S)-6-CYCLOHEXYL- 5,8-DIOXO-4,7-DIAZABICYCLO[14.3.1]ICOSA- 1(20),16,18-TRIEN-3-YL]CARBONYL}AMINO)- 2-OXOHEXANOYL]GLYCYL}AMINO)(PHENYL)ACETIC ACID | A,C | 2A4Q | 0.72 | |
5FH | (5S)-5-benzylimidazolidine-2,4- dione | A | 2JLO | 0.73 | |
ING | D-[(AMINO)CARBONYL]PHENYLALANINE | A,B | 1UF8 | 0.72 | |
ING | D-[(AMINO)CARBONYL]PHENYLALANINE | A,B,D,E | 1HDU | 0.72 | |
DFK | D-PHENYLALANYL-N-[(1S)-4-{[(Z)- AMINO(IMINO)METHYL]AMINO}-1-(CHLOROACETYL)BUTYL]- L-PROLINAMIDE | H,L | 3E6P | 0.72 | |
AJH | 4-({4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]- 1,4-diazepan-1-yl}carbonyl)benzoic acid | A,B | 3EIO | 0.73 | |
PI1 | A,B | 1B6J | 0.73 | ||
CS7 | N'-[(1S,2R)-2-[(2R,4R)-4-(BENZYLOXY)PYRROLIDIN- 2-YL]-1-(3,5-DIFLUOROBENZYL)-2- HYDROXYETHYL]-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE | A,B | 2QMD | 0.71 | |
DKT | 4-[2-(3-BENZYLOXYCARBONYLAMINO- 4-CYCLOHEXYL-1-HYDROXY-2-OXO-BUTYLAMINO)- 5-GUANIDINO-PENTANOYLAMINO]-4-(1- CARBOXY-2-CYCLOHEXYL-ETHYLCARBAMOYL)- BUTYRIC ACID | A,B,C,D,E,F | 1N6F | 0.75 | |
T16 | BOROLOG2 | H | 1A3E | 0.76 | |
VSC | A | 1EWO | 0.78 | ||
LHY | L-[(N-HYDROXYAMINO)CARBONYL]PHENYLALANINE | A,B,D,E | 1HEE | 0.71 | |
MOQ | MOTUPORIN | A | 2BCD | 0.73 | |
FAF | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1- FORMYL-2-PHENYL-ETHYL)-AMIDE | B,C | 1GGD | 0.75 | |
K7I | L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-alaninamide | A,B | 2QXG | 0.73 | |
BLN | MORPHOLINE-4-CARBOXYLIC ACID [1S- (2-BENZYLOXY-1R-CYANO-ETHYLCARBAMOYL)- 3-METHYL-BUTYL]AMIDE | A | 1MS6 | 0.79 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1R1I | 0.72 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1QF1 | 0.72 | |
HV8 | BENZYL-2-AMINO-PARAMETHOXY-BENZYLSTATINE | C | 1A8G | 0.7 | |
BBL | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | A,I | 2H9H | 0.75 | |
BBL | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | A,I | 2HAL | 0.75 | |
BBL | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | A | 2A4O | 0.75 | |
BBL | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | A,I | 2H6M | 0.75 | |
BBL | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | A | 2CXV | 0.75 | |
K2Z | benzyl [(1S)-1-{[(1S,2S)-1-ethyl- 2-hydroxy-3-{[3-(4-methylpiperazin- 1-yl)propyl]amino}-3-oxopropyl]carbamoyl}- 3-methylbutyl]carbamate | A | 2R9F | 0.79 | |
FVF | O-((((N-PHENYL-METHOXY-CARBONYL)- PHENYL ALANYL-CARBONYL)AMINO)-ISOBUTYL)HYDROXY PHOSPHINYL)- 3-PHENYLACETIC ACID | A | 7CPA | 0.79 | |
22U | D-phenylalanyl-N-(3-chlorobenzyl)- L-prolinamide | H,I | 2ZC9 | 0.74 | |
46U | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclohexyloxy)ethanoyl)pyrrolidine- 2-carboxamide | H,I | 2ZFR | 0.71 | |
46U | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclohexyloxy)ethanoyl)pyrrolidine- 2-carboxamide | A | 2ZDM | 0.71 | |
GGO | (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL- 5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN- 2-ONE | B | 2OQI | 0.71 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXI | 0.77 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXH | 0.77 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXJ | 0.77 | |
X23 | (3S,6S,7R,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- 7-(aminomethyl)-N-(diphenylmethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D,E,F, G,H,I,J | 3CM2 | 0.72 | |
EAL | 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)- L-PROLINE | A | 1UZE | 0.8 | |
IZD | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.74 | |
32U | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}- L-prolinamide | H,I | 2ZDA | 0.74 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.71 | |
PI4 | 1-[2-(8-CARBAMOYLMETHYL-6,9-DIOXO- 2-OXA-7,10-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14-TRIEN-11-YL)-2- HYDROXY-ETHYL]-PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1B6L | 0.71 | |
KI2 | 3-BENZYLOXYCARBONYLAMINO-2-HYDROXY- 4-PHENYL-BUTYRIC ACID | A,B,I,J | 1NH0 | 0.79 | |
KI2 | 3-BENZYLOXYCARBONYLAMINO-2-HYDROXY- 4-PHENYL-BUTYRIC ACID | I | 1U8G | 0.79 | |
GB6 | (3R,4R,5R)-3,4-dihydroxy-5-({[(1R)- 2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidin- 2-one | A | 3DDF | 0.71 | |
C78 | [1-[1-(6-CARBAMOYL-CYCLOHEX-2-ENYLCARBAMOYL)- CYCLOHEXYLCARBAMOYL]-2-(4-PHOSPHONOOXY- PHENYL)- ETHYL]-CARBAMIC ACID 3- AMINOBENZYLESTER | A,B,C,D,E,F, G,H,I,J,K,L | 1CJ1 | 0.71 | |
OIR | N-(3-PHENYL-2-SULFANYLPROPANOYL)PHENYLALANYLALANINE | A | 1R1J | 0.74 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4H | 0.7 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4G | 0.7 | |
UNH | ({1-[1-CARBAMOYL-PHENYL-METHYL)- CARBAMOYL]-METHYL}-AMINOOXALYL)- BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL)- CYCLOHEXYL-METHYL)-CARBAMIC ACID ISOBUTYL ESTER | A,C | 2A4G | 0.75 | |
SB3 | 1,3-DIPHENYL-1-PROPYL-1-(3,3-DIMETHYL- 1,2-DIOXYPENTYL)-2-PIPERIDINE CARBOXYLATE | A | 1FKG | 0.78 | |
0E2 | N-acetyl-L-valyl-O-benzyl-L-threonyl- N-[(1R,2R)-2-hydroxy-1-{[(3R)-2- oxopyrrolidin-3-yl]methyl}propyl]- L-leucinamide | A | 2Z3C | 0.77 | |
DRR | A,B | 3BXR | 0.78 | ||
998 | N-METHYLALANYL-3-METHYLVALYL-N- (1,2,3,4-TETRAHYDRONAPHTHALEN-1- YL)PROLINAMIDE | A | 1TFQ | 0.73 | |
HU2 | (2S)-({N-[(3S)-3-({N-[(2S,4E)-2- ISOPROPYL-7-METHYLOCT-4-ENOYL]- L-LEUCYL}AMINO)-2-OXOHEXANOYL]GLYCYL}AMINO)(PHENYL)ACETIC ACID | A,C | 2OC1 | 0.72 | |
ZFB | (3R)-3-{[(BENZYLOXY)CARBONYL]AMINO}- 2-OXO-4-PHENYLBUTANE-1-DIAZONIUM | A,B,C,D | 1PVJ | 0.89 | |
419 | N-[(3aR,6S,6aS)-1-(N-methyl-L-alanyl- 3-methyl-L-valyl)octahydrocyclopenta[b]pyrrol- 6-yl]-2,2-diphenylacetamide | A,B | 3F7H | 0.74 | |
GB7 | (3R,4R,5R)-3,4-dihydroxy-5-({[(1R)- 2-hydroxy-1-phenylethyl]amino}methyl)- 1-methylpyrrolidin-2-one | A | 3DDG | 0.72 | |
PI5 | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2- OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14- TRIEN-11-YLAMINO)- 2-HYDROXY-1-(4-HYDROXY-BENZYL)- PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN- 1-YL)-BUTYRAMIDE | A,B | 1B6K | 0.76 | |
PKF | CARBOBENZOXY-PRO-LYS-PHE-Y(PO2)- ALA-PRO-OME | A | 1QJI | 0.83 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A,B | 1J36 | 0.8 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A,B | 2C6N | 0.8 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A | 1O86 | 0.8 | |
SBA | CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE | A | 1BQI | 0.79 | |
AG6 | N-[(benzyloxy)carbonyl]-L-alpha- glutamyl-N-[(1S)-4-oxo-4-phenyl- 1-propylbut-2-en-1-yl]-L-phenylalaninamide | A | 3FRZ | 0.8 | |
49U | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclopentylpropanoyl)pyrrolidine- 2-carboxamide | A | 2ZDN | 0.7 | |
49U | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclopentylpropanoyl)pyrrolidine- 2-carboxamide | H,I | 2ZHF | 0.7 | |
PI6 | [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO- 2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA- 1(16),13(17),14-TRIEN-11-YLAMINO)- 2-HYDROXY-PROPYL] -CARBAMIC ACID TERT- BUTYL ESTER | A,B | 1B6M | 0.76 | |
AAF | METHYL 4-{[({[(2R,5S)-5-{[(2S)- 2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN- 2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE | B | 2G63 | 0.73 | |
NOL | N-[(BENZYLOXY)CARBONYL]-O-(TERT- BUTYL)-L-THREONYL-3-CYCLOHEXYL- N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN- 3-YL]METHYL}ETHYL]-L-ALANINAMIDE | A | 2GX4 | 0.81 | |
ZYA | BENZOYL-TYROSINE-ALANINE-METHYL KETONE | A | 1AIM | 0.84 | |
XIN | methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin- 1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}- 2-oxo-2,3-dihydro-1H-indole-6-carboxylate | A | 3C7Q | 0.7 | |
HA2 | 6-[{(2S)-2-AMINO-3-[4-(BENZYLOXY)PHENYL]PROPYL}(HYDROXY)AMINO]- 6-OXOHEXANOIC ACID) | A | 2VJ8 | 0.77 | |
PI7 | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2- OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA- 1(16),13(17),14-TRIEN-11-YAMINO)- 2-HYDROXY-1-(4-HYDROXY-BENZYL) - PROPYL]-3-METHYL-2-PROPIONYLAMINO- BUTYRAMIDE | A,B | 1B6P | 0.74 | |
77B | BENZYL N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN- 2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | A | 2DCC | 0.8 | |
PP6 | METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)- 2-(HYDROXYL-(1S)-1-METHYLOXYCARBONYL- 2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]- 1-NAPHTHALENEACETAMIDE] | A | 2WED | 0.71 | |
PP6 | METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)- 2-(HYDROXYL-(1S)-1-METHYLOXYCARBONYL- 2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]- 1-NAPHTHALENEACETAMIDE] | A | 2WEA | 0.71 | |
11U | (S)-N-(4-carbamimidoylbenzyl)-1- (2-(cyclohexylamino)ethanoyl)pyrrolidine- 2-carboxamide | H,I | 3BIV | 0.71 | |
TR1 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)- AMINO]-3-MERCAPTO-PENTANOYLAMINO}- ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER | A,B | 1C8T | 0.71 | |
TR1 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)- AMINO]-3-MERCAPTO-PENTANOYLAMINO}- ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER | A,B | 1C3I | 0.71 | |
U16 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY- 3-(4-ISOPROPYLPHENYL)PROPANOYL]- D-ALANYL-D-LEUCINATE | A | 2GG9 | 0.73 | |
WR1 | NALPHA-[(BENZYLOXY)CARBONYL]-N- [(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]- L-PHENYLALANINAMIDE | A,B | 2OP9 | 0.88 | |
ENB | ETHYL (2E,4S)-4-[((2R)-2-{[N-(TERT- BUTOXYCARBONYL)-L-VALYL]AMINO}- 2-PHENYLETHANOYL)AMINO]-5-[(3S)- 2-OXOPYRROLIDIN-3-YL]PENT-2-ENOATE | A,B | 2D2D | 0.77 | |
Y15 | N-[(1S)-2-{[(1R)-2-(benzyloxy)- 1-cyano-1-methylethyl]amino}-1- (cyclohexylmethyl)-2-oxoethyl]morpholine- 4-carboxamide | A,B | 2R9O | 0.8 | |
LGG | N-ACETYL-L-ALPHA-GLUTAMYL-L-PHENYLALANYL- L-GLUTAMINYL-N-[(1S)-4-AMINO-1- (2-CARBOXYETHYL)-4-OXOBUTYL]-L- LEUCINAMIDE | A,B | 2IPH | 0.74 | |
BR4 | 6-PHENYL-4(R)-(7-PHENYL-HEPTANOYLAMINO)- HEXANOIC ACID | A | 1KQU | 0.75 | |
M1N | (1R)-3-METHYL-1-{[N-(MORPHOLIN- 4-YLCARBONYL)-3-(1-NAPHTHYL)-D- ALANYL]AMINO}BUTYLBORONIC ACID | 2,C,E,G,H,J, L,N,P,R,T,V, X,Z | 2FHH | 0.7 | |
INA | 1,5-BIS(N-BENZYLOXYCARBONYL-L-LEUCINYL)CARBOHYDRAZIDE | A | 1AYU | 0.82 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.78 | |
73V | BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN- 2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | A | 2DC6 | 0.79 | |
T10 | [1-(1-BENZYL-3-HYDROXY-2-OXO-PROPYLCARBAMOYL)- 2-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER | A | 1ME4 | 0.86 | |
PHP | (2-PHENYL-1-CARBOBENZYL-OXYVALYL- AMINO)-ETHYL-PHOSPHINIC ACID | A | 1HOS | 0.79 | |
PHW | BETA-PHENYL-N-{[(PHENYLMETHYL)OXY]CARBONYL}- D-PHENYLALANYL-N- [(1S,3E)-1-[DIHYDROXY(METHYLOXY)(PHENYLOXY)- LAMBDA5-PHOSPHANYL]-4- (METHYLOXY)BUT- 3-ENYL]-D-PROLINAMIDE | I,K | 1H8I | 0.8 | |
PHW | BETA-PHENYL-N-{[(PHENYLMETHYL)OXY]CARBONYL}- D-PHENYLALANYL-N- [(1S,3E)-1-[DIHYDROXY(METHYLOXY)(PHENYLOXY)- LAMBDA5-PHOSPHANYL]-4- (METHYLOXY)BUT- 3-ENYL]-D-PROLINAMIDE | I,K | 1H8D | 0.8 | |
G26 | 2-(BENZYLCARBAMOYL-PHENYLACETYLAMINO- METHYL)-5,5-DIMETHYL-THIAZOLIDINE- 4-CARBOXYLIC ACID (HYDROXYMETHYL- 2-PHENYLETHYL)AMIDE | A,B | 1HTF | 0.7 | |
BCC | 6-AMINO-6-BENZYL-5-OXO-OCTAHYDRO- INDOLIZINE-3-CARBALDEHYDE | H,I,R | 1B5G | 0.75 | |
D7G | ((1S)-1-((((1S)-1-BENZYL-3-(CYCLOPROPYLAMINO)- 2,3-DIOXOPROPYL)AMINO)CARBONYL)- 3-METHYLBUTYL)CARBAMIC ACID 5-METHOXY- 3-OXAPENTYL ESTER | A | 2G8J | 0.75 | |
CST | [[PHENYLALANINE-CARBONYL-AMINO- 2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN- 4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL- GLYCYL]PHENYLALANINE | A,B | 1BCS | 0.71 | |
CST | [[PHENYLALANINE-CARBONYL-AMINO- 2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN- 4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL- GLYCYL]PHENYLALANINE | A | 1SGC | 0.71 | |
TI3 | [(2S)-2-SULFANYL-3-PHENYLPROPANOYL]- GLY-(5-PHENYLPROLINE) | A | 1QF2 | 0.76 | |
5NH | A,C | 2F9U | 0.73 | ||
AIP | ANTIPAIN | A,B | 1BCR | 0.72 | |
SD2 | N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE | A,B | 1PWQ | 0.74 | |
U15 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY- 3-(4-METHYLPHENYL)PROPANOYL]-D- ALANYL-D-LEUCINATE | A | 2GG8 | 0.74 | |
ZPR | N-BENZYLOXYCARBONYL-L-PROLYL-L- PROLINAL | A | 1QFS | 0.87 | |
ZPR | N-BENZYLOXYCARBONYL-L-PROLYL-L- PROLINAL | A | 1H2Y | 0.87 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.73 | |
23U | beta-phenyl-D-phenylalanyl-N-(3- chlorobenzyl)-L-prolinamide | H,I | 3DHK | 0.71 | |
3TL | BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)- 8,11-DIBENZYL-9,10-DIHYDROXY-5,14- DIISOPROPYL-3,6,13,16-TETRAOXO- 4,7,12,15-TETRAAZAOCTADECANE-2,17- DIYLDICARBAMATE | A,B | 2P3C | 0.77 | |
3TL | BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)- 8,11-DIBENZYL-9,10-DIHYDROXY-5,14- DIISOPROPYL-3,6,13,16-TETRAOXO- 4,7,12,15-TETRAAZAOCTADECANE-2,17- DIYLDICARBAMATE | A | 2P3D | 0.77 | |
3TL | BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)- 8,11-DIBENZYL-9,10-DIHYDROXY-5,14- DIISOPROPYL-3,6,13,16-TETRAOXO- 4,7,12,15-TETRAAZAOCTADECANE-2,17- DIYLDICARBAMATE | A,B | 2P3B | 0.77 | |
3TL | BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)- 8,11-DIBENZYL-9,10-DIHYDROXY-5,14- DIISOPROPYL-3,6,13,16-TETRAOXO- 4,7,12,15-TETRAAZAOCTADECANE-2,17- DIYLDICARBAMATE | A,B | 2P3A | 0.77 | |
997 | 1-[3,3-DIMETHYL-2-(2-METHYLAMINO- PROPIONYLAMINO)-BUTYRYL]-4-PHENOXY- PYRROLIDINE-2-CARBOXYLIC ACID(1,2,3,4- TETRAHYDRO-NAPHTHALEN-1-YL)-AMIDE | A | 1TFT | 0.73 | |
SDK | 1,3-BIS[[N-[(PHENYLMETHOXY)CARBONYL]- L-LEUCYL]AMINO]-2-PROPANONE | A | 1AU0 | 0.87 | |
A70 | N-ethyl-N-[(4-methylpiperazin-1- yl)carbonyl]-D-phenylalanyl-N-[(1S,2S,4R)- 4-(butylcarbamoyl)-1-(cyclohexylmethyl)- 2-hydroxy-5-methylhexyl]-L-norleucinamide | A | 1ZAP | 0.7 | |
0EZ | tert-butyl [(1S,2S)-1-benzyl-2- hydroxy-3-{[(8S,11R)-8-[(1R)-1- methylpropyl]-7,10-dioxo-2-oxa- 6,9-diazabicyclo[11.2.2]heptadeca- 1(15),13,16-trien-11-yl]amino}propyl]carbamate | A,B | 1MTR | 0.76 | |
50U | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclohexylpropanoyl)pyrrolidine- 2-carboxamide | A | 2ZDK | 0.72 | |
50U | (S)-N-(4-carbamimidoylbenzyl)-1- (3-cyclohexylpropanoyl)pyrrolidine- 2-carboxamide | H,I | 2ZG0 | 0.72 | |
U11 | METHYL N-{(2S,3R)-3-AMINO-2-HYDROXY- 3-[4-(TRIFLUOROMETHYL)PHENYL]PROPANOYL}ALANYLGLYCINATE | A | 2GG0 | 0.73 | |
BEI | N,N-[2,5-O-[DIBENZYL]-GLUCARYL]- DI-[ISOLEUCYL-AMIDO-METHANE] | A | 1EBW | 0.72 | |
CT2 | 1-(PHENYLMETHYL)CYCLOPENTYL[(1S)- 1-FORMYLPENTYL]CARBAMATE | A | 2AUZ | 0.77 | |
VS2 | 3-[N-[BENZYLOXYCARBONYL]-PHENYLALANINYL- AMINO]-5-PHENYL-PENTANE-1-SULFONYLMETHYLBENZENE | A | 1F2A | 0.81 | |
INT | [[PHENYLMETHYLOXY-CARBONYL]-ALANINYL]- VALINYL-[PHENYL-1-HYDROXYPROP-2- YL]-AMINE | A | 3TLH | 0.86 | |
INT | [[PHENYLMETHYLOXY-CARBONYL]-ALANINYL]- VALINYL-[PHENYL-1-HYDROXYPROP-2- YL]-AMINE | A | 1B11 | 0.86 | |
INT | [[PHENYLMETHYLOXY-CARBONYL]-ALANINYL]- VALINYL-[PHENYL-1-HYDROXYPROP-2- YL]-AMINE | A | 6FIV | 0.86 | |
INT | [[PHENYLMETHYLOXY-CARBONYL]-ALANINYL]- VALINYL-[PHENYL-1-HYDROXYPROP-2- YL]-AMINE | A | 5FIV | 0.86 | |
INT | [[PHENYLMETHYLOXY-CARBONYL]-ALANINYL]- VALINYL-[PHENYL-1-HYDROXYPROP-2- YL]-AMINE | A | 2HAH | 0.86 | |
INF | D-[(N-HYDROXYAMINO)CARBONYL]PHENYLALANINE | A | 1HDQ | 0.71 | |
0PN | N-[(benzyloxy)carbonyl]-L-valyl- L-alanyl-N~5~-[amino(iminio)methyl]- L-ornithyl-L-serine | A | 3G8F | 0.76 | |
CHY | CHYMOSTATIN | A,B | 1M21 | 0.72 | |
CHY | CHYMOSTATIN | A,B | 1WVM | 0.72 | |
NPG | N-SUCCINYL PHENYLGLYCINE | A,B,C,D | 1SJD | 0.72 | |
64U | 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)- L-prolinamide | H,I | 3DUX | 0.73 | |
DI5 | AC-(D)PHE-PRO-BOROHOMOORNITHINE- OH | H | 1LHG | 0.79 | |
LPF | 1,1,1-TRIFLUORO-3-((N-ACETYL)-L- LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N- ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) | G | 7GCH | 0.72 | |
PCM | 1-[N[(PHENYLMETHOXY)CARBONYL]-L- LEUCYL-4-[[N/N-[(PHENYLMETHOXY)CARBONYL]- /NL-LEUCYL]AMINO]-3-PYRROLIDINONE/N | A | 1AU3 | 0.89 | |
SUB | 3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PROPIONIC ACID ETHYL ESTER | A | 1J4H | 0.71 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1JLA | 0.74 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1RT2 | 0.74 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1S1V | 0.74 | |
33U | beta-phenyl-D-phenylalanyl-N-(4- carbamimidoylbenzyl)-L-prolinamide | H,I | 2ZO3 | 0.71 | |
27U | N-(4-carbamimidoylbenzyl)-1-(3- phenylpropanoyl)-L-prolinamide | H,I | 2ZHQ | 0.74 | |
PPB | 1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)- PYRROLIDINE-2-CARBONYL]-AMINO}- 2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID | A | 1AUJ | 0.78 | |
177 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]- PYRROLIDINE-3-CARBOXYLIC ACID 5- CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)- BENZYLAMIDE | A,B | 1TA6 | 0.72 | |
903 | 2-{4-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-METHOXYCARBONYL-PHENYL}- 2-FLUORO-MALONIC ACID | A | 1O46 | 0.72 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.75 | |
HTA | N-[3-(N'-HYDROXYCARBOXAMIDO)-2- (2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE- N-METHYLAMIDE | A | 1FBL | 0.77 | |
COC | COCAINE | A,C | 1I7Z | 0.7 | |
COC | COCAINE | H | 1Q72 | 0.7 | |
COC | COCAINE | L | 2AJV | 0.7 | |
COC | COCAINE | A,B,C,D,E | 2PGZ | 0.7 | |
BAV | (3S,14R,16S)-16-[(1R)-1-hydroxy- 2-{[3-(1-methylethyl)benzyl]amino}ethyl]- 3,4,14-trimethyl-1,4-diazacyclohexadecane- 2,5-dione | A,B,C | 3DV5 | 0.72 | |
C4P | N-[(1R)-2-(BENZYLSULFANYL)-1-FORMYLETHYL]- N-(MORPHOLIN-4-YLCARBONYL)-L-PHENYLALANINAMIDE | A | 1NQC | 0.71 | |
CT1 | (1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)- 1-FORMYLPENTYL]CARBAMATE | A | 2AUX | 0.76 | |
G6A | N-cyclopropyl-2',6-dimethyl-4'- (5-methyl-1,3,4-oxadiazol-2-yl)biphenyl- 3-carboxamide | A | 3E92 | 0.7 | |
NDF | N-(CARBOXYCARBONYL)-D-PHENYLALANINE | A | 1YCI | 0.74 | |
578 | (5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]- 6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL- 2,7-DIOXA-4-AZA-6-PHOSPHANONAN- 9-OIC ACID 6-OXIDE | A,B,C | 2PJ1 | 0.72 | |
JNH | 1-[2-(S)-AMINO-3-BIPHENYL-4-YL- PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE | I,J | 2AJL | 0.78 | |
197 | 4-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-FORMYL-BENZOIC ACID | A | 1O4A | 0.72 | |
ZU3 | N-[(benzyloxy)carbonyl]-3-[(2,2- dimethylpropanoyl)amino]-L-alanyl- N-[(1R)-4-oxo-1-{[(3S)-2-oxopyrrolidin- 3-yl]methyl}pentyl]-L-leucinamide | A | 2ZU4 | 0.86 | |
ZU3 | N-[(benzyloxy)carbonyl]-3-[(2,2- dimethylpropanoyl)amino]-L-alanyl- N-[(1R)-4-oxo-1-{[(3S)-2-oxopyrrolidin- 3-yl]methyl}pentyl]-L-leucinamide | A | 2ZU3 | 0.86 | |
565 | (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]- 3-METHYL-1,4-DIAZEPAN-2-ONE | A,B | 2IIV | 0.7 | |
BHP | (S)-5-(4-BENZYLOXY-PHENYL)-4-(7- PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID | A,B | 1J1A | 0.74 | |
AZ0 | ethyl (5S,8S,14S)-14-hydroxy-5,8,11- tris(2-methylpropyl)-3,6,9,12-tetraoxo- 1-phenyl-2-oxa-4,7,10,11-tetraazapentadecan- 15-oate | A,B,C,D | 3GCD | 0.71 | |
MTJ | N,O-DIMETHYL-L-TYROSINE | A,B | 1ATL | 0.71 | |
3BC | A,C | 2FM2 | 0.71 | ||
ALD | CARBOBENZYLOXYLEUCINYL-LEUCINYL- LEUCINAL | A | 1BP4 | 0.83 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.74 | |
BIC | 3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO- 1,6-DIAZANONAN-2-ONE | H,I | 1A5G | 0.71 | |
BIC | 3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO- 1,6-DIAZANONAN-2-ONE | H,I | 1A46 | 0.71 | |
BIC | 3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO- 1,6-DIAZANONAN-2-ONE | H,I | 1A61 | 0.71 | |
AZP | (5S,8S,14R)-ETHYL 11-(3-AMINO-3- OXOPROPYL)-8-BENZYL-14-HYDROXY- 5-ISOBUTYL-3,6,9,12-TETRAOXO-1- PHENYL-2-OXA-4,7,10,11-TETRAAZAPENTADECAN- 15-OATE | A | 2A5I | 0.75 | |
AZP | (5S,8S,14R)-ETHYL 11-(3-AMINO-3- OXOPROPYL)-8-BENZYL-14-HYDROXY- 5-ISOBUTYL-3,6,9,12-TETRAOXO-1- PHENYL-2-OXA-4,7,10,11-TETRAAZAPENTADECAN- 15-OATE | A | 2GTB | 0.75 | |
AZP | (5S,8S,14R)-ETHYL 11-(3-AMINO-3- OXOPROPYL)-8-BENZYL-14-HYDROXY- 5-ISOBUTYL-3,6,9,12-TETRAOXO-1- PHENYL-2-OXA-4,7,10,11-TETRAAZAPENTADECAN- 15-OATE | A,B | 2A5K | 0.75 | |
TVN | N-{(2R)-4-(methylamino)-4-oxo-2- [4-(phosphonooxy)benzyl]butanoyl}- L-valyl-L-aspartamide | A | 3C7I | 0.7 | |
RBE | 3-(BENZOYLOXY)-8-AZA-BICYCLO[3.2.1]OCTANE- 2-CARBOXYLIC ACID | H | 1RIU | 0.73 | |
ATN | N-[(2S,3R)-3-AMINO-2-HYDROXY-4- PHENYL-BUTANOYL]-L-PROLYL-L-PROLYL- L-ALANINAMIDE | A | 1N51 | 0.76 | |
MIN | METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE | H,I | 1TOM | 0.79 | |
WRG | N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]- L-ornithyl-N-methyl-L-phenylalanine | A,B | 3CHD | 0.74 | |
DI2 | AC-(D)PHE-PRO-BOROLYS-OH | H | 1LHD | 0.79 | |
MMI | N-[(4S,5S,7R)-8-({(S)-1-[(BENZYLAMINO)OXOMETHYL]- 2-METHYLPROPYL}AMINO)-5-HYDROXY- 2,7-DIMETHYL-8-OXO-OCT-4-YL]-(4S,7S)- 4-ISOPROPYL-2,5,9-TRIOXO-1-OXA- 3,6,10-TRIAZACYCLOHEXADECANE-7- CARBOXAMIDE | D | 1XS7 | 0.7 | |
959 | benzyl (2-oxopropyl)carbamate | A | 3D62 | 0.75 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 2GST | 0.71 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 6GSW | 0.71 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 6GSV | 0.71 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A | 1B4P | 0.71 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 6GSX | 0.71 | |
GPS | (9S,10S)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE | A,B | 6GSU | 0.71 | |
51U | D-phenylalanyl-N-(3-methylbenzyl)- L-prolinamide | H,I | 2ZF0 | 0.78 | |
Q50 | {(1S)-1-BENZYL-4-[3-CARBAMOYL-1- (1-CARBAMOYL-2-PHENYL-ETHYLCARBAMOYL)- (S)-PROPYLCARBAMOYL]-2-OXO-5-PHENYL- PENTYL}-CARBAMIC ACID TERT-BUTYL ESTER | A,B | 1IZI | 0.74 | |
Q50 | {(1S)-1-BENZYL-4-[3-CARBAMOYL-1- (1-CARBAMOYL-2-PHENYL-ETHYLCARBAMOYL)- (S)-PROPYLCARBAMOYL]-2-OXO-5-PHENYL- PENTYL}-CARBAMIC ACID TERT-BUTYL ESTER | B | 1IZH | 0.74 | |
AGF | O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)- ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3- L-PHENYLLACTATE | A | 8CPA | 0.8 | |
SK2 | (3R)-METHYLCARBAMOYL-7-SULFOAMINO- 3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER | A | 2F6V | 0.78 | |
MP2 | N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE | A,B | 2FU9 | 0.78 | |
1BH | N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO- 4-PHENYL-BUTAN-2-OL | A | 1BH6 | 0.9 | |
DRS | (9S,12S)-9-(1-methylethyl)-7,10- dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca- 1(16),14,17-triene-12-carboxylic acid | A,B | 3BXS | 0.76 | |
BNH | [(N-{3-[(N-{CYCLOHEXYL[(ISOBUTOXYCARBONYL)AMINO]ACETYL}- 3-CYCLOPROPYLALANYL)AMINO]-4-CYCLOPROPYL- 2-OXOBUTANOYL}GLYCYL)AMINO](PHENYL)ACETIC ACID | A,C | 2A4R | 0.74 | |
864 | (2S)-2-[3-(AMINOMETHYL)PHENYL]- 3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}- 2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID | A,B,C | 2PJ2 | 0.75 | |
BJI | 1(R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | A | 1ERM | 0.72 | |
37U | D-phenylalanyl-N-(3-fluorobenzyl)- L-prolinamide | H,I | 2ZDV | 0.78 | |
INZ | 2-{4-[(2S)-2-[({[(1S)-1-CARBOXY- 2-PHENYLETHYL]AMINO}CARBONYL)AMINO]- 3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID | A | 1G7F | 0.72 | |
853 | 5-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-CARBOXYMETHYL-BENZOIC ACID | A | 1O48 | 0.72 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2HBY | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2H4Y | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2HBR | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2H4W | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2H48 | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2H54 | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2H51 | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2HBZ | 0.81 | |
F3G | 3-[2-(2-BENZYLOXYCARBONYLAMINO- 3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID | A | 2HBQ | 0.81 | |
1C5 | [[O-PHOSPHONO-N-ACETYL-TYROSINYL]- GLUTAMYL-3[CYCLOHEXYLMETHYL]ALANINYL]- AMINE | A | 1BKM | 0.72 | |
S17 | methyl 4-bromo-N-[8-(hydroxyamino)- 8-oxooctanoyl]-L-phenylalaninate | A,B,C,D | 2VCG | 0.72 | |
0E3 | N-acetyl-L-valyl-O-benzyl-L-threonyl- N-[(1R)-2-oxo-1-{[(3S)-2-oxopyrrolidin- 3-yl]methyl}propyl]-L-leucinamide | A | 2Z3C | 0.8 | |
ZAH | N-[(BENZYLOXY)CARBONYL]-L-ALANYL- L-PROLINE | A,B | 2BKL | 0.87 | |
53U | D-phenylalanyl-N-benzyl-L-prolinamide | H,I | 2ZFF | 0.8 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AH8 | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1HCJ | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7S | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7T | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AHA | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EME | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 1KP5 | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EMM | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EML | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7U | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1EMC | 0.77 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 2HPW | 0.77 | |
M18 | {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin- 2-yl}methyl (3-chlorophenyl)acetate | H,I | 3EGK | 0.76 | |
MYE | N2-({[(4-BROMOPHENYL)METHYL]OXY}CARBONYL)- N1-[(1S)-1-FORMYLPENTYL]-L-LEUCINAMIDE | A | 1SNK | 0.81 | |
PME | N-L-ALPHA-ASPARTYL L-PHENYLALANINE 1- METHYL ESTER | H,L | 1A8J | 0.75 | |
DFM | N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]- L-PHENYLALANINAMIDE | A | 2CMC | 0.71 | |
Y14 | N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin- 3-yl]amino}-1-(cyclohexylmethyl)- 2-oxoethyl]morpholine-4-carboxamide | A,B | 2R9N | 0.71 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.76 | |
NBL | N2-[(BENZYLOXY)CARBONYL]-N1-[(3S)- 1-CYANOPYRROLIDIN-3-YL]-L-LEUCINAMIDE | A | 1YK7 | 0.88 | |
SMK | (3S,6S,7R,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- 7-(2-aminoethyl)-N-(diphenylmethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B | 3EYL | 0.73 | |
002 | N-[(2R)-2-BENZYL-4-(HYDROXYAMINO)- 4-OXOBUTANOYL]-L-ISOLEUCYL-L-LEUCINE | A,B | 2FV9 | 0.72 | |
AZL | 1-ETHOXYCARBONYL-D-PHE-PRO-2(4- AMINOBUTYL)HYDRAZINE | H,I | 1AE8 | 0.8 | |
PP8 | 2-[(1R)-1-(N-(3-METHYLBUTANOYL)- L-VALYL-L-ASPARAGINYL)-AMINO)-3- METHYLBUTYL]HYDROXYPHOSPHINYLOXY]- 3-PHENYLPROPANOIC ACID METHYLESTER | A | 1BXQ | 0.71 | |
ZYZ | (4-{(2S)-2-[(tert-butoxycarbonyl)amino]- 3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid | A | 3D9C | 0.74 | |
BJP | (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | A | 1ERO | 0.76 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.73 | |
DI4 | AC-(D)PHE-PRO-BOROHOMOLYS-OH | H | 1LHF | 0.79 | |
BI6 | (3S,6S,7Z,10AS)-N-(DIPHENYLMETHYL)- 6-{[(2S)-2-(METHYLIDENEAMINO)BUTANOYL]AMINO}- 5-OXO-1,2,3,5,6,9,10,10A-OCTAHYDROPYRROLO[1,2- A]AZOCINE-3-CARBOXAMIDE | A | 2JK7 | 0.74 | |
CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.8 | |
T29 | TRI166 (BIFUNCTIONAL BORONATE INHIBITOR) | H | 1A3B | 0.71 |